ProSomnus Announces Strong First Quarter 2024 Revenue Growth
May 16, 2024 08:42 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
May 13, 2024 09:00 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
May 09, 2024 18:30 ET
|
ProSomnus Sleep Technologies, Inc.
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
May 08, 2024 20:53 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
March 26, 2024 16:05 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
March 15, 2024 20:01 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
February 22, 2024 08:30 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
February 20, 2024 16:05 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call & Participation at the 36th Annual ROTH Conference in March 2024
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
January 30, 2024 08:00 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
January 29, 2024 08:00 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices